Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Clinical trial NCT02721732 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02721732
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Carcinoma of Unknown Primary Metastatic Adrenal Gland Pheochromocytoma Metastatic Kidney Medullary Carcinoma Metastatic Malignant Germ Cell Tumor Metastatic Malignant Solid Neoplasm Metastatic Paraganglioma Metastatic Penile Carcinoma Metastatic Skin Squamous Cell Carcinoma Small Cell Carcinoma Stage III Adrenal Cortex Carcinoma AJCC v7 Stage IV Adrenal Cortex Carcinoma AJCC v7

Start date: 2016-08-15
Primary completion: 2028-12-31
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.